Candid Therapeutics

Closed

Rewriting the Biology of Autoimmune Disease

San Diego, United States · Founded 2024 · $875.0M raised

Employees
11–50
Founded
2024
Business Model
B2B
Total Funding
$875.0M
Last Round
$505.0M Venture RoundMar 2026
Rounds
2

About

Candid Therapeutics is a clinical-stage biopharmaceutical company developing bispecific antibody therapies for autoimmune and inflammatory diseases. Founded in 2023 and backed by $370M in funding, the company is building a pipeline of next-generation immunology treatments targeting unmet medical needs in conditions such as lupus and myasthenia gravis.

Summary

Candid Therapeutics is a Biotech company based in San Diego, United States, founded in 2024. It has raised $875.0M in total across 2 rounds, most recently a $505.0M Venture Round round in Mar 2026.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

MergerMerger with RallybioMar 2026

Sign up to see all 3 rounds

Seed through Venture Round — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Candid Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/candid-therapeutics"><img src="https://indexed.vc/api/badge/company/candid-therapeutics" alt="Candid Therapeutics on Indexed.vc" width="260" height="76" /></a>